Laura I Furlong
Overview
Explore the profile of Laura I Furlong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
4207
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
De Paepe A, Giannoula A, Garcia-Gorro C, Rodriguez-Dechicha N, Vaquer I, Calopa M, et al.
Arch Clin Neuropsychol
. 2025 Feb;
PMID: 39909861
Objective: Although Huntington's disease is characterized by motor onset, psychiatric disturbances may present years prior and affect functioning. However, there is inter-individual variability in psychiatric expression and progression. This study...
2.
Corvi J, Diaz-Roussel N, Fernandez J, Ronzano F, Centeno E, Accuosto P, et al.
J Cheminform
. 2025 Feb;
17(1):15.
PMID: 39901182
Over the last few decades the pharmaceutical industry has generated a vast corpus of knowledge on the safety and efficacy of drugs. Much of this information is contained in toxicology...
3.
Giannoula A, De Paepe A, Sanz F, Furlong L, Camara E
Sci Rep
. 2025 Jan;
15(1):3081.
PMID: 39856140
One of the principal goals of Precision Medicine is to stratify patients by accounting for individual variability. However, extracting meaningful information from Real-World Data, such as Electronic Health Records, still...
4.
Niarakis A, Ostaszewski M, Mazein A, Kuperstein I, Kutmon M, Gillespie M, et al.
Front Immunol
. 2024 Feb;
14:1282859.
PMID: 38414974
Introduction: The COVID-19 Disease Map project is a large-scale community effort uniting 277 scientists from 130 Institutions around the globe. We use high-quality, mechanistic content describing SARS-CoV-2-host interactions and develop...
5.
Gawron P, Hoksza D, Pinero J, Pena-Chilet M, Esteban-Medina M, Fernandez-Rueda J, et al.
Front Bioinform
. 2023 Jul;
3:1101505.
PMID: 37502697
Investigation of molecular mechanisms of human disorders, especially rare diseases, require exploration of various knowledge repositories for building precise hypotheses and complex data interpretation. Recently, increasingly more resources offer diagrammatic...
6.
Valls-Margarit J, Pinero J, Fuzi B, Cerisier N, Taboureau O, Furlong L
Front Pharmacol
. 2023 Jul;
14:1225697.
PMID: 37502213
Network-based methods are promising approaches in systems toxicology because they can be used to predict the effects of drugs and chemicals on health, to elucidate the mode of action of...
7.
Sanz F, Pognan F, Steger-Hartmann T, Diaz C, Asakura S, Amberg A, et al.
Nat Rev Drug Discov
. 2023 Jun;
22(8):605-606.
PMID: 37316648
No abstract available.
8.
Pinero J, Rodriguez Fraga P, Valls-Margarit J, Ronzano F, Accuosto P, Lambea Jane R, et al.
Comput Struct Biotechnol J
. 2023 Mar;
21:2110-2118.
PMID: 36968019
The use of molecular biomarkers to support disease diagnosis, monitor its progression, and guide drug treatment has gained traction in the last decades. While only a dozen biomarkers have been...
9.
Callegaro G, Schimming J, Pinero Gonzalez J, Kunnen S, Wijaya L, Trairatphisan P, et al.
iScience
. 2023 Mar;
26(3):106094.
PMID: 36895646
Animal testing is the current standard for drug and chemicals safety assessment, but hazards translation to human is uncertain. Human models can address the species translation but might not replicate...
10.
Perez-Granado J, Pinero J, Furlong L
Front Genet
. 2022 Oct;
13:1006903.
PMID: 36276939
Our knowledge of complex disorders has increased in the last years thanks to the identification of genetic variants (GVs) significantly associated with disease phenotypes by genome-wide association studies (GWAS). However,...